Home > Personal Investment Vitae
Location: United States
Gender: Female
Asset investment style: Quantitative fundamental analysis
Market capitalization:
$7,326,611talentsVirtual portfolio value:
$4,354,347talentsNet overall return per annum:
17.29%AYA current rank order:
#15Asset investment philosophy:
Apple Boston trades U.S. stocks with the top #226 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| UBXG | U-BX Technology Ltd. Class A Ordinary Shares | $0.34 | $3.98 | 38,608 | +1,070.59% | $140,533 |
| UMAC | Unusual Machines Inc. Common Stock | $1.87 | $18.73 | 7,019 | +901.60% | $118,340 |
| SXTP | 60 Degrees Pharmaceuticals Inc. Common Stock | $0.15 | $1.34 | 80,273 | +793.33% | $95,525 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 11,933 | +2,108.33% | $90,571 |
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 22,718 | +681.13% | $82,012 |
| SSNT | SilverSun Technologies Inc. Common Stock | $18.59 | $130.48 | 629 | +601.88% | $70,379 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 1,509 | +589.24% | $61,975 |
| HZNP | Horizon Therapeutics Public Limited Company Ordinary Shares | $16.41 | $98.56 | 640 | +500.61% | $52,576 |
| TUEM | Tuesday Morning Corp. Common Stock | $0.12 | $0.69 | 90,033 | +475.00% | $51,319 |
| MRNS | Marinus Pharmaceuticals Inc. Common Stock | $1.94 | $11.62 | 3,749 | +498.97% | $36,290 |
| Sum | $799,520 |
Top 10 current stock portfolio positions as of March 2026Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| HIMS | Hims & Hers Health Inc. Class A Common Stock | $22.02 | 1,286 | $28,317 |
| ETON | Eton Pharmaceuticals Inc. Common Stock | $22.32 | 1,099 | $24,529 |
| TSEM | Tower Semiconductor Ltd. Ordinary Shares | $163.63 | 149 | $24,380 |
| CNR | Core Natural Resources Inc. Common Stock | $107.17 | 227 | $24,327 |
| NRXS | Neuraxis Inc. Common Stock | $7.62 | 3,114 | $23,728 |
| VIST | Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value | $72.06 | 323 | $23,275 |
| NET | Cloudflare Inc. Class A Common Stock | $215.42 | 108 | $23,265 |
| ESCA | Escalade Incorporated Common Stock | $17.55 | 1,297 | $22,762 |
| ASTH | Astrana Health Inc. Common Stock | $24.23 | 919 | $22,267 |
| AMR | Alpha Metallurgical Resources Inc. Common Stock | $193.69 | 114 | $22,080 |
| Sum | $238,930 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Dan Rochefort | @Andy Yeh Alpha | ||
| @Daisy Harvey | |||
| @Laura Hermes | |||
| @Charlene Vos | |||
| @Chanel Holden |
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
| @TechBull22 | @Ru-Ting Yeh | @Syl_will | @George |
2019-10-03 17:39:00 Thursday ET
President Trump indicates that he would consider an interim Sino-American trade deal in lieu of a full trade agreement. The Trump administration defers high
2022-02-25 00:00:00 Friday ET
Empirical tests of multi-factor models for asset return prediction The capital asset pricing model (CAPM) of Sharpe (1964), Lintner (1965), and Bla
2025-07-12 11:35:00 Saturday ET
Mitch Anthony explains why it is now more important for top sales leaders to apply social skills and emotional competences to fulfill customer needs, wants,
2023-04-14 13:32:00 Friday ET
Calomiris and Haber delve into the comparative analysis of bank crises and politics in America, Britain, Canada, Mexico, and Brazil. Charles Calomiris an
2020-06-17 09:23:00 Wednesday ET
Successful founders focus on their continuous growth, passion, perseverance, and the collective wisdom of most team members. William Ferguson (2013) &
2018-05-07 07:32:00 Monday ET
President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri